EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS073-08850 
Organism
Homo sapiens 
Tissue/cell
GM19238 
Coordinate
chr2:225758170-225760220 
TF binding sites/motifs
Number: 9             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
FOXA1MA0148.4chr2:225760118-225760134AATTATTTACATAATC-6.02
MAFGMA0659.1chr2:225758473-225758494ATTTTGCAGTCTCAGCAACTC-6.02
NFAT5MA0606.1chr2:225758312-225758322ATTTTCCATT+6.02
NFATC1MA0624.1chr2:225758312-225758322ATTTTCCATT+6.02
NFATC3MA0625.1chr2:225758312-225758322ATTTTCCATT+6.02
Rhox11MA0629.1chr2:225759026-225759043TTTCTTTACAGCATCAT-6.08
SPI1MA0080.4chr2:225759221-225759235AGAAAGAGGAAGTC+6.21
SPICMA0687.1chr2:225759221-225759235AGAAAGAGGAAGTC+6.67
Sox6MA0515.1chr2:225758971-225758981CCATTGTTTT+6.02
Number of super-enhancer constituents: 2             
IDCoordinateTissue/cell
SE_11129chr2:225757515-225763655CD20
SE_18264chr2:225757474-225760548CD4p_CD25-_Il17-_PMAstim_Th
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 3             
ChromosomeStartEnd
chr2225758480225759400
chr2225759181225759393
chr2225759100225759430
Number: 1             
IDChromosomeStartEnd
GH02I224893chr2225758527225760539
Enhancer Sequence
AAAAATTTTA ATATGTCACA CATCTCTGTA TTTTACCCAG TGGATTAATG AAATCAGTGG 60
CATCATATAT TTTTATGCTG CTTTTTTCTT CTGGGATCTC CAAGTTAGTG CTGATTTCTA 120
TTCCTAGTGT GTAAAGGCTT ACATTTTCCA TTCTAGCCTG AAGTCATCTA TTTCTTCAGT 180
ATCTTCCTAT GGACCCTCGC TTAAAAATAA AAAAAGTGAA AATCTTAAGA GTCAATAATA 240
CACATTTAAA TTTAAAGAAT AAATTTCACC TTTTTTTTTG CTTTTCTATA ATTGCAAATT 300
TTCATTTTGC AGTCTCAGCA ACTCATAAAA AGAAATAAGC AATTTAAATT GGTAGCAGAC 360
ATAGGAGAAT TCTTCTAATC CAGGAGGTAT GAAAATGATT TACTTCTATT AGCCTCGGAA 420
GACCCAAGTA AATTGTCTGT TTCCATTACT GACCTAAATA CATGTAGTCT TTAGAGGGGA 480
ATGCTTAGCT TTGTAAAATC ATTTTAAAGA ATAATTCTGC TGTTCAGTGC TCATCTTCAT 540
TGTTCTGGGG TATATCTGAA AGGGTTATAT TTTTGAACTT CTGATTTTCA GTTTGAATAC 600
ATAAAGTTTC TTACTTTGTG GCAGTCTGAT TCTTCCCTTT CTTGGTATTA ACTTCCACTT 660
TCTTTAGTTA AAGTAAGGGA AATTCTCAAC AATACTTCAG TTAATTTTTT TTATTTCTTC 720
TCATGAGATT AATCTTGCAA ACTATGAGAA TTGCAATTAA GCAATAATGT CCGGGATTGG 780
TTTTTTCTAG AGATGCTTTC TCCATTGTTT TAACAGAGGA AGAATACTGT GAATGTGAAA 840
TCTCTAATTT GCTTTCTTTC TTTACAGCAT CATGAATATA AGGAAAGATG AACAGTGTTT 900
GGGGATACAG CCACTGAAGA GTGTAATGGA CCTAAAGATG GTGGGAACAC ATTTAGTTAA 960
AAGGATGGCT AAATACGGCT GTCTCCATCC TCTCAACTTG AGATGCAGTC TCCCAACTTC 1020
CGAGTTGTAA CCACTTCTCA GAACTATTTT CAGAAAGAGG AAGTCCTGAT GTTAAAAGAT 1080
GCTTTGCTTT TCAGTTGTGC CTACAAAAAC TGTGTCATGA ACACCCAGAC ATTCTGAATG 1140
TAACAATTAC TCATGAAAGC TTAGGGTGTG GTAAACCTTC CCAACATGAA GTTGCAAGAG 1200
CTTGTCTATC AGCAGGGATT CAAGTCAAAA AGAATGCTCA AAGATCTGGT AAACGTTACT 1260
GTTCAGTGTT TTGAAAAAAG ATTTGCAGTT TAGAAGGGAC ATACTTTTTT TCTCTTCACG 1320
GTAATGAAAC CCCAAAATAA ATGGCCTCCT CCTGTCTTTT TCTTCGATTG CCACCCCTGC 1380
AGTCCCATTC TCCATAGAGT AGCCCAAGAG TTCTTTCAAA GAGGTAAACC AGATCATGCC 1440
ACACCCCTGG TTGAAATTTC CAAAGGCTTT TGTTGCAATG AAAGTAAAAT CCAAGCTCCT 1500
TTCCAGGGCA CACAGGGTCC CTTGCCTAAG GTCCTTGGTT TCATCTTATT ACGCCCCTTT 1560
CATCCTTAAG CTCTAGCCTT CCTGACTCAA GTGACCATAC TGGTTCCCAC CACTTCAGGG 1620
TCTTTGCCTT GCTGCTTCTC CAGAATCCTT TCCCAAGATG CCTGTGTTGG CAGCTACTGC 1680
CGATTCATAT CCAAGATCAA ATGTCACCTT CTTAAATCTA GTTCATAATC CCTCTTTCAA 1740
ATTCCGCATT CGGAAATTGA GAGCAATGCT TCCAAGTATA CAAGTCTTGA AAAGGTGCTT 1800
CTGGGGCCAC AGGAAATATA GCAAAGTGGT TCCCAATTCT GTACCATGTG TCTATTAAAA 1860
ATTAGATCCA ATGTGTATCA TATCAGTGCT TCACTTGAGG AGAGTGTTAA TACAAACTTA 1920
ACTTTTGATT GTTTCAAGTG TTTTTCTGAA TTATTTACAT AATCTTAGCT TGATGAACCA 1980
GTGAGTTGGG TAGAACCAGT TCAAGGAAGT TCTTTAAATA TGAGCAACTC CAAACCCATC 2040
CAGGAATATT 2050